Dashboard
1
Poor Management Efficiency with a low ROCE of 2.44%
- The company has been able to generate a Return on Capital Employed (avg) of 2.44% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
3
With a growth in Operating Profit of 109.32%, the company declared Very Positive results in Sep 25
4
With ROE of 7.79%, it has a fair valuation with a 2.28 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
SAR 3,888 Million (Small Cap)
29.00
NA
0.00%
0.65
12.37%
2.44
Revenue and Profits:
Net Sales:
406 Million
(Quarterly Results - Dec 2025)
Net Profit:
42 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.5%
0%
12.5%
6 Months
7.82%
0%
7.82%
1 Year
12.7%
0%
12.7%
2 Years
-16.82%
0%
-16.82%
3 Years
-6.09%
0%
-6.09%
4 Years
-30.25%
0%
-30.25%
5 Years
17.82%
0%
17.82%
Saudi Pharmaceutical Industries & Medical Appliances Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.36%
EBIT Growth (5y)
66.36%
EBIT to Interest (avg)
0.76
Debt to EBITDA (avg)
170.08
Net Debt to Equity (avg)
0.83
Sales to Capital Employed (avg)
0.57
Tax Ratio
40.66%
Dividend Payout Ratio
22.66%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.44%
ROE (avg)
2.09%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
2.28
EV to EBIT
28.33
EV to EBITDA
17.18
EV to Capital Employed
1.75
EV to Sales
2.72
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
6.19%
ROE (Latest)
7.79%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
405.80
386.20
5.08%
Operating Profit (PBDIT) excl Other Income
69.40
12.90
437.98%
Interest
25.70
37.60
-31.65%
Exceptional Items
0.30
-1.90
115.79%
Consolidate Net Profit
42.10
-37.20
213.17%
Operating Profit Margin (Excl OI)
134.60%
-25.50%
16.01%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 5.08% vs 16.82% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 213.17% vs 24.70% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,706.70
1,682.00
1.47%
Operating Profit (PBDIT) excl Other Income
323.70
203.90
58.75%
Interest
98.10
95.80
2.40%
Exceptional Items
-1.60
5.00
-132.00%
Consolidate Net Profit
196.80
31.80
518.87%
Operating Profit Margin (Excl OI)
132.80%
70.90%
6.19%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 1.47% vs 1.61% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 518.87% vs 179.50% in Dec 2024
About Saudi Pharmaceutical Industries & Medical Appliances Corp. 
Saudi Pharmaceutical Industries & Medical Appliances Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






